Review
Published on 05 Nov 2025
Durvalumab consolidation therapy in patients with stage III small cell lung cancer after concurrent chemoradiation: a China-based cost-effectiveness analysis
in Cancer Immunity and Immunotherapy
- 866 views
Review
Published on 05 Nov 2025
in Cancer Immunity and Immunotherapy
Original Research
Published on 05 Nov 2025
in Stroke
Original Research
Published on 05 Nov 2025
in Neuro-Otology
Original Research
Published on 05 Nov 2025
in Pediatric Psychology
Original Research
Published on 05 Nov 2025
in Immunological Tolerance and Regulation
Clinical Trial
Published on 05 Nov 2025
in Translational Pharmacology
Original Research
Published on 05 Nov 2025
in Physical Oceanography
Original Research
Published on 05 Nov 2025
in Pulmonary Medicine
Original Research
Published on 05 Nov 2025
in International Studies
Original Research
Published on 05 Nov 2025
in Health Psychology
Case Report
Published on 05 Nov 2025
in Neuro-Oncology and Neurosurgical Oncology
Review
Published on 05 Nov 2025
in Pediatric Psychology
Review
Published on 05 Nov 2025
in Translational and Clinical Endocrinology
Original Research
Published on 05 Nov 2025
in General Cardiovascular Medicine
Review
Published on 05 Nov 2025
in Addictive Disorders
Original Research
Published on 05 Nov 2025
in Pediatric Critical Care